Pharmaceuticals (Feb 2022)

Anxiolytic-like Effects of the Positive GABA<sub>B</sub> Receptor Modulator GS39783 Correlate with Mice’s Individual Basal Anxiety and Stress Reactivity

  • Ahmet Oguzhan Bicakci,
  • Mousumi Sarkar,
  • Yu-Hsin Chang,
  • Evelyn Kahl,
  • Lorenzo Ragazzi,
  • Angel Moldes-Anaya,
  • Markus Fendt

DOI
https://doi.org/10.3390/ph15020233
Journal volume & issue
Vol. 15, no. 2
p. 233

Abstract

Read online

Positive gamma-aminobutyric acid type B (GABAB) receptor modulators such as GS39783 have showed anxiolytic-like effects in several studies while such effects were absent in other studies. These conflicting findings led us hypothesize that the anxiolytic-like effects of such compounds depend on the individual basal anxiety and/or the anxiogenic properties of the used tests. The present study addresses this hypothesis by testing GS39783 effects on mice’s anxiety-like behavior in a light–dark box. We found that GS39783 had no effects on a whole-group level. However, after grouping the mice for their basal anxiety, GS39783 reduced anxiety-like behavior in the subgroup with highest basal anxiety. Moreover, GS39783 effects correlated with individual basal anxiety. Next, the anxiogenic properties of the light–dark box test were increased by prior stress exposure. Again, GS39783 was not effective on a whole-group level. However, GS39783 had an anxiolytic-like effect in the most stress-responsive subgroup. Moreover, GS39783 effects correlated with individual stress responsiveness. Finally, we show that GS39783 brain levels were within a behaviorally relevant range. Overall, our study demonstrates that GS39783 effects depend on individual basal anxiety and stress responsiveness. This suggests that anxiety tests should generally be designed to capture individual basal anxiety and/or stress responsiveness as well as individual compound effects.

Keywords